Hereditary Disorders Startups in APAC

There are 13 Hereditary Disorders digital health ventures in APAC. Over the past 5 years, the CAGR has not expanded. The average maturity of digital health ventures in Hereditary Disorders is 68.9.

In total, $1.57B of digital health venture capital has been raised across 58 funding deals.

Here is a list of 10 promising HealthTech startups!

Last Updated: January 17, 2022

Ventures

ShowEntries

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
23 Mofang (23魔方)	Omics Related Applications	China	$ 123.46 B	$ 123.46 B	Series B2	$ 8.67 M	Toggle
Aegicare (安吉康尔)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	Series B	$ 15.42 M	Toggle
Basecare Medical (贝康医疗)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	IPO	$ 233.00 M	Toggle
Berry Genomics (贝瑞和康)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	IPO	$ 624.85 M	Toggle
BGI Genomics (华大基因)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	IPO	$ 74.95 M	Toggle
GeneKang (基云惠康)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	Series A	undisclosed	Toggle
GeneMind Biosciences (真迈生物)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	Series C	$ 55.90 M	Toggle
GrandOmics (希望组)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	Series B	$ 14.53 M	Toggle
MedGenome	Omics Related Research	India	$ 123.46 B	$ 123.46 B	Series E	$ 50.00 M	Toggle
Mega Genomics (美因基因)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	IPO	$ 15.30 M	Toggle

Showing 1 to 10 of 13 entries